Company Overview - The company is a professional biotechnology enterprise engaged in the research, production, sales, and service of biological enzyme preparations, biosynthetic products, and plant extracts, providing comprehensive biotechnology solutions across eight major fields [6][10]. Business Segments Biological Enzyme Preparations - Biological enzyme preparations are high-efficiency, specific, and environmentally friendly catalysts widely used in various industries, including feed, food, energy, pharmaceuticals, textiles, and environmental protection. The enzyme preparation industry in China is in a growth phase, driven by government policies and increasing demand from downstream industries [6][7]. Biosynthetic Products - Biosynthetic products are created using biological technology to produce compounds with specific biological activity through metabolic pathways. The company has developed a platform for organic acid research, achieving industrialization standards at the small trial level [8]. Plant Extracts - The company offers both animal and human plant extracts, with animal extracts including various veterinary raw materials and formulations that have received national approval. These products are designed to reduce antibiotic use in animal feed, aligning with the trend towards green farming [9][15]. Industry Development Biotechnology Industry - The biotechnology sector continues to receive strong policy support from the government, with initiatives aimed at accelerating the development of strategic emerging industries, including biological manufacturing. The goal is to enhance the stability and competitiveness of the industrial supply chain [10][11]. Agricultural and Animal Husbandry Industry - China is the largest producer and consumer of pork globally, with the pig farming industry transitioning towards more centralized operations. The government has implemented measures to regulate pig production capacity, which is expected to improve profitability in the sector [13]. Market Position - The company aims to become a benchmark enterprise in the global biological enzyme preparation market and a leader in China's animal nutrition and health industry. It is the first listed company in China's biological enzyme preparation sector and the largest manufacturer in Asia [14]. Financial Highlights - The company has not needed to restate previous financial data, indicating stability in its financial reporting [16]. Shareholder Information - The company has completed the election of its eighth board of directors and supervisory board, ensuring governance continuity [18]. Recent Developments - The company has acquired a 49% stake in Germany's Victory Enzymes GmbH to enhance its overseas market presence and operational efficiency [19][20].
广东溢多利生物科技股份有限公司2024年年度报告摘要